1,143
Views
14
CrossRef citations to date
0
Altmetric
HEMOGLOBINOPATHY

Iron-chelation therapy with oral chelators in patients with thalassemia major

&
Pages 50-55 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

John Porter, Ali Taher, Vip Viprakasit, Antonis Kattamis, Thomas D Coates, Maciej Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard & M. Domenica Cappellini. (2021) Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Expert Review of Hematology 14:7, pages 633-644.
Read now
Adriana Ceci, Rosa Conte, Antonella Didio, Donato Bonifazi, Mariagrazia Felisi, Viviana Giannuzzi & Fedele Bonifazi. (2019) An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload. Expert Opinion on Orphan Drugs 7:4, pages 181-197.
Read now

Articles from other publishers (12)

Subhangi Basu, Motiur Rahaman, Tuphan Kanti Dolai, Praphulla Chandra Shukla & Nishant Chakravorty. (2023) Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review. Thalassemia Reports 13:3, pages 179-194.
Crossref
Gian Luca Forni, Giuliano Grazzini, Jeanne Boudreaux, Vanessa Agostini & Laurel Omert. (2023) Global burden and unmet needs in the treatment of transfusion-dependent β-thalassemia. Frontiers in Hematology 2.
Crossref
Pritam Kumar Pain, Dipanwita Palit, Meenakshi Shegane, Rajnish Pratap Singh & Debasish Manna. (2023) Optochemical control of Cu( i ) homeostasis in mammalian cells . Chemical Communications 59:16, pages 2315-2318.
Crossref
Graciela Terán, Hanxiong Li, Sergiu-Bogdan Catrina, Ruining Liu, Susanna Brighenti, Xiaowei Zheng, Jakob Grünler, Susanne Nylén, Berit Carow & Martin E. Rottenberg. (2022) High Glucose and Carbonyl Stress Impair HIF-1-Regulated Responses and the Control of Mycobacterium tuberculosis in Macrophages. mBio 13:5.
Crossref
Immacolata Tartaglione, Roberta Carfora, Davide Brotto, Maria Rosaria Barillari, Giuseppe Costa, Silverio Perrotta & Renzo Manara. (2021) Hearing Loss in Beta-Thalassemia: Systematic Review. Journal of Clinical Medicine 11:1, pages 102.
Crossref
James Joseph Phelan, Kate McQuaid, Colin Kenny, Karl Michael Gogan, Dónal J. Cox, Sharee Ann Basdeo, Seónadh O’Leary, Simone Christa Tazoll, Cilian Ó Maoldomhnaigh, Mary P. O’Sullivan, Luke A. O’Neill, Maureen J. O’Sullivan & Joseph Keane. (2020) Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis. Frontiers in Immunology 11.
Crossref
Abdel Nasser El-Shorbagi & Sachin Chaudhary. (2019) Monobactams: A Unique Natural Scaffold of Four-Membered Ring Skeleton, Recent Development to Clinically Overcome Infections by Multidrug- Resistant Microbes. Letters in Drug Design & Discovery 16:12, pages 1305-1320.
Crossref
Mikhael Yosia & Pustika Amalia Wahidiyat. (2018) Side effect of deferiprone as iron chelator in patient with thalassemia. Paediatrica Indonesiana 57:6, pages 329.
Crossref
Francesco Viola, Giulio Barteselli, Laura Dell'Arti, Diego Vezzola, Chiara Mapelli, Edoardo Villani & Roberto Ratiglia. (2014) MULTIMODAL IMAGING IN DEFEROXAMINE RETINOPATHY. Retina 34:7, pages 1428-1438.
Crossref
Diana X. Nichols-Vinueza, Matthew T. White, Andrew J. Powell, Puja Banka & Ellis J. Neufeld. (2014) MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients. American Journal of Hematology 89:7, pages 684-688.
Crossref
Joshua P. Gray & Sidhartha D. Ray. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 323 337 .
Mohamad H Qari, Yasser Wali, Muneer H Albagshi, Mohammad Alshahrani, Azzah Alzahrani, Ibrahim A Alhijji, Abdulkareem Almomen, Abdullah Aljefri, Hussain H Al Saeed, Shaker Abdullah, Ahmad Al Rustumani, Khoutir Mahour & Shaker A Mousa. (2013) Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area. Orphanet Journal of Rare Diseases 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.